Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Tight liquidity NBB
Cash and receivables cover 12 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
BMJ II from Zaventem, company number BE0657787286, closed financial year 2024 with a result of € -139,664 after tax. For that financial year BMJ II recorded a gross margin of € 311,444 and equity of € -249,714. Compared with financial year 2023, the result moved from € -127,952 to € -139,664. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2025.
€ -249,714
▼ € 139,664 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -139,664
▼ 9 % more loss than in 2023
Profit after tax over the fiscal year.
€ 79,861
▼ 18% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -268,314.
People and assets in 2024
11
▲ 5 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 333,644
▲ 102% vs 2023
€ 30,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,015
▲ € 2,457 vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 482,401
€ 48,895 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 635,889
▲ 75% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 62,098
▲ 300% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 74,242 | € 80,978 | € 39,382 | € 311,444 | ▲ € 272,061 |
| Profit after taxes | € -42,389 | € -376 | € -127,952 | € -139,664 | ▼ € 11,712 |
| Equity | € 18,277 | € 17,902 | € -110,050 | € -249,714 | ▼ € 139,664 |
| Total debts | € 94,643 | € 66,902 | € 496,803 | € 1,292,480 | ▲ 160% |
| Cash | € 48,921 | € 43,840 | € 97,733 | € 79,861 | ▼ 18% |
| Retained profit | € -323 | € -698 | € -128,650 | € -268,314 | ▼ € 139,664 |
| Bank debt | € 0 | € 0 | € 0 | € 482,401 | |
| Balance sheet total | € 112,921 | € 84,804 | € 386,753 | € 1,042,766 | ▲ 170% |
| Employees (FTE) | - | - | 6 | 11 | ▲ 5 |
Key figures of BMJ II, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to BMJ II?
What happened at BMJ II in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 139,664. Source: NBB ↗
- New establishment in Zaventem. KBO
- Bassel JABER became a director. NBB
- Bachar JABER became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 42,389 loss in 2021 to € 139,664 loss in 2024.
Paid € 721 in corporate taxes since 2021.
On average € 28,300 of value added per employee in 2024.
A new publication or filing at BMJ II? We notify you, reason included.
Follow BMJ IIDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BMJ II are Bassel JABER and Bachar JABER. Bassel JABER is also behind BROTHERS JABER and JABER HOLDING.
Directors
According to the 2024 annual accounts
since 2020
Bachar JABER
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Weerstandslaan 8A
1930 Zaventem
Stationsstraat 68
1930 Zaventem
Active since 1 April 2023
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0657.787.286
- VAT number
- BE 0657.787.286
- Registered office
- Weerstandslaan 8A, 1930 Zaventem
- Names & denominations
- BMJ II
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 June 2016
- Peppol
- Active · Active since 8 Sept 2025
- Activities · NACE
Niet-gespecialiseerde detailhandel waarbij voedings- en genotmiddelen overheersen
Detailhandel in niet-gespecialiseerde winkels waarbij voedings- en genotmiddelen overheersen (verkoopsoppervlakte tussen 100 m² en minder dan 400 m²)
Detailhandel in niet-gespecialiseerde winkels waarbij voedings- en genotmiddelen overheersen (verkoopsoppervlakte tussen 400 m² en minder dan 2500 m²)